Lakeway, NY -- (SBWIRE) -- 02/04/2013 -- ThePennyStockProfiler.com, an investment community with a special focus on updating investors with recent news on the U.S. stock market, issues news alert on the following stocks:-
Baidu.com, Inc. (ADR) (NASDAQ:BIDU) stock gained 0.24% to $108.87 in the pre-market hour trading. The company is scheduled to report 4Q 2012 earnings after the closing bell on today, Monday, February 4. The actual results are expected to come through between 4:00 and 4:30 p.m. EST with a conference call slated to follow at 8:00 p.m. The average estimate of analysts is for profit of $1.28 per share, a rise of 37.6% from the company’s actual earnings for the same quarter a year ago.
According to a post on Benzinga.com last month, Citigroup reiterated a Sell rating and lowered the price target on Baidu to $90. The firm noted that Baidu is in a transition period toward mobile and cloud-computing.
How Should Investors Trade BIDU After The Recent Turmoil? Get Special Trend Analysis Coverage Here
The Medicines Company (NASDAQ:MDCO) is licensing the rights to cholesterol-lowering drug ALN-PCS from Alnylam Pharmaceuticals (ALNY), with Medicines paying $25M up front, as much as $180M in milestones, and then royalties. The treatment inhibits a protein called PCSK9 and is seen as an alternative to statins such as Lipitor. However, ALN-PCS is only in Phase I trials.
Is MDCO a Buy After The Recent Report? Don’t Miss our Special Coverage Here
Chevron Corporation (NYSE:CVX) stock declined 1.16% to $115.15 in the pre-market hour trading. A state agency issued a nearly $1 million fine against Chevron last week in response to the Richmond refinery fire that occurred last August. The California Division of Occupational Safety and Health issued 25 citations against Chevron, with penalties amounting to $963,200. The fines levied against Chevron are the highest allowed by the state.
Get Latest News, Free Trend Analysis On CVX Here
Acme Packet, Inc. (NASDAQ:APKT) shares climbed 21.90% to $29.17 in the pre-market hour after Oracle Corp today said it has agreed to buy Acme Packet Inc for about $2 billion. The $29.25 per share offer represents a 22 percent premium to Acme Packet's Friday close on the Nasdaq. The deal value is based on the number of outstanding shares as of Dec 31.
Additionally, the company will unveil its latest earnings tomorrow, Monday, February 4, 2013. The average analyst estimate is for a loss of 5 cents per share, a spike from profit of 13 cents in the year-ago quarter.
Is APKT a Buy After The Recent news? Find Out Here
Humana Inc. (NYSE:HUM) reported lower fourth-quarter earnings that still exceeded analysts' expectations as the company kept control of rising costs. The company said that net income had fallen to $192 million, or $1.19 a share, from $199 million, or $1.20 per share, a year earlier. Analysts on average had expected earnings of $1.06 per share. Fourth-quarter revenue rose 6% to $9.56 billion from $9.06 billion, missing the analysts' average estimate of $9.73 billion.
How Should Investors Trade HUM After The Recent Turmoil? Get Special Trend Analysis Coverage Here
ThePennyStockProfiler.com is engaged in providing the most up to date and useful information on Microcap Stocks poised to breakout. ThePennyStockProfiler.com also provides investors with trend analysis, detailed company profiles, and most importantly a much needed "informational edge" which can be used as a tool for making investment decisions. To Receive Instant updates in the inbox, readers are advised to sign up for free at www.ThePennyStockProfiler.com
The assembled information disseminated by ThePennyStockProfiler.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. ThePennyStockProfiler.com does expect that investors will buy and sell securities based on information assembled and presented in phd-trading.com. PLEASE always do your own due diligence, and consult your financial advisor.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)